Subscribe To
Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc
The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate...
November 4, 2023, 12:00 pm
Buy hershey amid financial and technical strength
The Hershey Company reported strong Q3 2023 financial results, with a substantial increase in net sales driven by organic sales growth and strategic p...
November 4, 2023, 6:23 am
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at
RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...
November 3, 2023, 11:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Pcar or tsla: which is the better value stock right now?
Investors interested in Automotive - Domestic stocks are likely familiar with Paccar (PCAR) and Tesla (TSLA). But which of these two stocks ...
November 3, 2023, 12:47 pm
Skx vs. nke: which stock is the better value option?
Investors interested in Shoes and Retail Apparel stocks are likely familiar with Skechers (SKX) and Nike (NKE). But which of these two stocks ...
November 3, 2023, 12:47 pm
Wish releases inaugural ‘anti-counterfeiting report’ as it continues to crack down on counterfeiters
SAN FRANCISCO, Nov. 03, 2023 (GLOBE NEWSWIRE) — ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of the world’s largest mobile ecommerce platfor...
November 3, 2023, 12:30 pm
Coherus presents data from next-generation immuno-oncology programs at 38th annual meeting of society for immunotherapy of cancer (sitc)
– Data demonstrate distinct IL-27-mediated expression of genes associated with immune suppression in vitro, supporting ongoing clinical development ...
November 3, 2023, 12:30 pm
Annaly capital management: this 16.6% yielding trust is a bargain (upgrade)
Stock price weakness in Annaly Capital Management presents an attractive entry point into the largest m...
November 3, 2023, 11:39 am
The power of compounding: 3 stocks for long-term wealth creation
In unpredictable financial markets, investors often seek the elusive formula for long-term wealth creation. The stock market, with its enticing prospe...
November 3, 2023, 11:33 am
Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...
November 3, 2023, 10:00 am
Maersk cuts jobs as profit collapses. it's bad news for global trade.
The shipping Giant's third-quarter Ebitda of $1.9 billion represents a fraction of last year's $10.9 bi...
November 3, 2023, 6:54 am
Alexandria real estate: a fast-growing and fairly valued reit
Alexandria Real Estate Equities specializes in developing Class A/A+ properties for the life science, agtech, and advanced technology industries. Desp...
November 2, 2023, 8:15 pm
Unlock massive gains: 3 tech stocks with outstanding value propositions for 2024
Autonomous systems, AI, quantum computing, and other groundbreaking technologies continue to redefine the way we live and interact. For those searchin...
November 2, 2023, 7:08 pm
This stock has a 6.05% yield and sells for less than book
the recent Ford share price of $9.91 represents a price-to-book ratio of 0.9 and an annual dividend yie...
November 2, 2023, 9:10 am
Ulta beauty: time to re-accelerate
The company was re-rated by the market as a mature value company, down from its past valuations, but ULTA still has a lot of room for growth. The comp...
November 2, 2023, 4:02 am